Article Details
Retrieved on: 2017-12-20 02:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The details show “a quite new and specific mechanism” that's worth exploring for potential treatments, says Richard Ransohoff, a neuroinflammation biologist at <b>Third Rock Ventures</b>, a venture capital firm in Boston. To be effective as a treatment, an antibody like the one in the study that kept A-beta from ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here